NCT03208829

Brief Summary

Subjects submitted to unilateral THA will be randomized into two rehabilitation groups. One group will receive a booklet with guidelines for postoperative care, while the other group will participate in face-to-face sessions with exercises with emphasis on muscle strengthening.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 1, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 6, 2017

Completed
10 months until next milestone

Study Start

First participant enrolled

May 4, 2018

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2020

Completed
Last Updated

April 7, 2020

Status Verified

April 1, 2020

Enrollment Period

2.2 years

First QC Date

July 1, 2017

Last Update Submit

April 4, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • 6 Weeks Post-Intervention Muscle Strength

    Muscle strength will be measured by a portable dynamometer and represented as muscle torque (N.m).

    Will be measured post intervention 6 weeks after intervention).

Secondary Outcomes (6)

  • Functional Capacity (TUG)

    Will be measured pre-intervention (30 days after the surgery), and two moments post intervention (1 week after intervention and 6 weeks after intervention).

  • Functional Capacity (HHS)

    Will be measured pre-intervention (30 days after the surgery), and two moments post intervention (1 week after intervention and 6 weeks after intervention).

  • Hip Range of Motion

    Will be measured pre-intervention (30 days after the surgery), and two moments post intervention (1 week after intervention and 6 weeks after intervention).

  • Pain in the operated hip (last seven days)

    Will be measured pre-intervention (30 days after the surgery), and two moments post intervention (1 week after intervention and 6 weeks after intervention).

  • 1 Week Post-Intervention Muscle Strength

    Will be measured post intervention (1 week after intervention).

  • +1 more secondary outcomes

Other Outcomes (4)

  • Body Mass Index

    Will be measured pre-intervention (30 days after the surgery), and two moments post intervention (1 week after intervention and 6 weeks after intervention).

  • Length of Lower Limbs

    Will be measured pre-intervention (30 days after the surgery), and two moments post intervention (1 week after intervention and 6 weeks after intervention).

  • Kinesiophobia

    Will be measured pre-intervention (30 days after the surgery), and two moments post intervention (1 week after intervention and 6 weeks after intervention).

  • +1 more other outcomes

Study Arms (2)

Group 1

EXPERIMENTAL

Rehabilitation Exercises Group 1 will be submitted to an exercise protocol based on muscle strength training, with duration of 6 weeks and frequency of two weekly sessions, lasting 45 minutes.

Other: Rehabilitation exercises

Group 2

ACTIVE COMPARATOR

Postoperative guidance Group 2 will receive an orientation booklet and weekly links from researchers to address possible questions.

Other: Postoperative guidance

Interventions

Patients in group 1 will participate in a physical exercise protocol supervised by a physiotherapist. The sessions will focus on the rehabilitation of muscle strength and the exercises will be performed with increased external load.

Group 1

Group 2 will receive only guidelines regarding postoperative care.

Group 2

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Referred by orthopedic doctors of the city of Porto Alegre, Rio Grande do Sul, Brazil;
  • Between 30-60 days of unilateral total hip arthroplasty (cemented and hybrid prostheses) postoperative phase;
  • Read and consent to the Free and Informed Consent Form and understood the guidelines necessary to carry out the evaluations proposed in this research.

You may not qualify if:

  • Performing a surgical procedure, in the last six months, in other articular joints in the lower limbs;
  • previous surgical procedures in the coxofemoral joint;
  • surgical procedures and osteoarticular diseases in the lumbar spine;
  • osteoarticular diseases in lower limb joints;
  • muscle injuries in lower limbs;
  • presence of signs or symptoms of osteoarthritis in the contralateral hip;
  • postoperative complications such as prosthesis dislocation, deep venous thrombosis, periarticular fractures and neural lesions;
  • intra-articular injection of corticosteroids in the lower limbs during the last six months;
  • cardiovascular diseases with presence of disability, such as severe dyspnea and uncontrolled arterial hypertension;
  • presence of neurological diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Federal Health Science University of Porto Alegre

Porto Alegre, Rio Grande do Sul, 90050-170, Brazil

RECRUITING

MeSH Terms

Conditions

Osteoarthritis, Hip

Interventions

Exercise Therapy

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy Modalities

Study Officials

  • Bruna M Lopes, PhD Student

    Federal Health Science University of Porto Alegre

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Bruna M Lopes, PhD Student

CONTACT

Marcelo F Silva, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The random allocation step will be conducted through Randomizers - www.random.org by a research assistant. The assistant responsible for randomization will not be involved in any other phase of the study and the secrecy of the allocation will be maintained through opaque envelopes. A second independent assistant will administer the agenda and all communication between the participants and the researchers involved
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients with total hip arthroplasty, will be assigned to two different treatment groups.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator (PhD student)

Study Record Dates

First Submitted

July 1, 2017

First Posted

July 6, 2017

Study Start

May 4, 2018

Primary Completion

July 1, 2020

Study Completion

September 1, 2020

Last Updated

April 7, 2020

Record last verified: 2020-04

Data Sharing

IPD Sharing
Will not share

Locations